Experience

Davis Polk advised Auris Medical Holding AG on its registered direct offering of 12,499,999 of its common shares and concurrent private placement of warrants to purchase up to 7,499,999 of…

Davis Polk advised the joint book-running managers in connection with the $133.7 million initial public offering of common stock of Solid Biosciences Inc. The common stock is listed on the…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering of 13,333,333 shares of common stock of ConforMis,…

Davis Polk advised the joint book-running managers in connection with a $115 million SEC-registered offering of 5,897,435 shares of common stock of Five Prime Therapeutics, Inc. The…

Davis Polk advised the representatives of the underwriters in connection with Gates Industrial Corporation plc’s initial public offering of 38,500,000 ordinary shares, at $19.00 per share,…

Davis Polk advised the joint book-running managers in connection with a $124.5 million SEC-registered follow-on offering of 3,000,000 shares of common stock of Adamas Pharmaceuticals, Inc…

Davis Polk advised the representatives of the several underwriters, in an SEC-registered offering by Ensco plc of $1 billion aggregate principal amount of its 7.75% senior notes due…

Davis Polk advised the sole dealer manager in connection with a cash tender offer by LINN Energy, Inc. for 6,770,833 shares of its Class A common stock at a purchase price of $48.00 per…

Davis Polk advised the global coordinators and bookrunners in connection with the initial public offering by PagSeguro Digital Ltd. and Universo Online S.A., as selling shareholder, of an…

Davis Polk advised the joint lead managers in connection with a $600 million 3.75% Regulation S bond offering by Sunny Optical Technology (Group) Company Limited. Sunny Optical Technology …